• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便与轻至中度溃疡性结肠炎患者粪便微生物群移植后的临床缓解及内镜反应相关。

Fecal Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis.

作者信息

van Thiel Isabelle A M, Rahman Shafaque, Hakvoort Theodorus B M, Davids Mark, Verseijden Caroline, van Hamersveld Patricia H P, Bénard Mèlanie V, Lodders Maarten H, Boekhout Teun, van den Wijngaard René M, Heinsbroek Sigrid E M, Ponsioen Cyriel Y, de Jonge Wouter J

机构信息

Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

Amsterdam Gastroenterology, Endocrinology, Metabolism (AGEM), 1105 AZ Amsterdam, The Netherlands.

出版信息

Microorganisms. 2022 Mar 29;10(4):737. doi: 10.3390/microorganisms10040737.

DOI:10.3390/microorganisms10040737
PMID:35456788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031408/
Abstract

Fecal microbiota transplantation (FMT) has the potential to restore (bacterial and fungal) microbial imbalance in ulcerative colitis (UC) patients and contribute to disease remission. Here, we aimed to identify fecal fungal species associated with the induction of clinical remission and endoscopic response to FMT for patients with mild-to-moderate ulcerative colitis. We analyzed the internal transcribed spacer 1 (ITS1)-based mycobiota composition in fecal samples from patients ( = 31) and donors ( = 7) that participated previously in a double-blinded randomized control trial evaluating the efficacy of two infusions of donor FMT compared with autologous FMT. The abundance of the yeast genus in fecal material used for transplantation was shown to correlate with clinical remission following FMT, irrespective of its presence in the material of donor or autologous fecal microbiota transfer. The amplified sequence variants within the genus most closely resembled . Monocyte-derived macrophages and HT29 epithelial cells were stimulated with fungal species. Especially elicited an IL10 response in monocyte-derived macrophages, along with secretion of other cytokines following stimulation with other species. No effect of spp. was seen on epithelial wound healing in scratch assays. In conclusion, the enriched presence of spp. in donor feces is associated with the positive response to FMT for patients with UC and hence it may serve as a predictive fungal biomarker for successful FMT.

摘要

粪便微生物群移植(FMT)有潜力恢复溃疡性结肠炎(UC)患者(细菌和真菌)的微生物失衡,并有助于疾病缓解。在此,我们旨在确定与轻至中度溃疡性结肠炎患者FMT诱导临床缓解和内镜反应相关的粪便真菌种类。我们分析了先前参与一项双盲随机对照试验的患者(n = 31)和供体(n = 7)粪便样本中基于内转录间隔区1(ITS1)的真菌群落组成,该试验评估了两次输注供体FMT与自体FMT的疗效。结果显示,用于移植的粪便材料中酵母属的丰度与FMT后的临床缓解相关,无论其在供体或自体粪便微生物群转移材料中是否存在。酵母属内扩增的序列变体与酿酒酵母最为相似。用真菌种类刺激单核细胞衍生的巨噬细胞和HT29上皮细胞。特别是酿酒酵母在单核细胞衍生的巨噬细胞中引发了IL10反应,以及在用其他酵母种类刺激后其他细胞因子的分泌。在划痕试验中未观察到酿酒酵母属对上皮伤口愈合的影响。总之,供体粪便中酿酒酵母属的丰富存在与UC患者对FMT的阳性反应相关,因此它可能作为FMT成功的预测性真菌生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/306958056b67/microorganisms-10-00737-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/e7ccf01e47d7/microorganisms-10-00737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/58c64c1c48b0/microorganisms-10-00737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/36fe577d4e60/microorganisms-10-00737-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/306958056b67/microorganisms-10-00737-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/e7ccf01e47d7/microorganisms-10-00737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/58c64c1c48b0/microorganisms-10-00737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/36fe577d4e60/microorganisms-10-00737-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98e8/9031408/306958056b67/microorganisms-10-00737-g004.jpg

相似文献

1
Fecal Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis.粪便与轻至中度溃疡性结肠炎患者粪便微生物群移植后的临床缓解及内镜反应相关。
Microorganisms. 2022 Mar 29;10(4):737. doi: 10.3390/microorganisms10040737.
2
Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.与活动性溃疡性结肠炎患者对胶囊化粪便微生物群移植反应相关的特定真菌。
Front Cell Infect Microbiol. 2023 Jan 5;12:1086885. doi: 10.3389/fcimb.2022.1086885. eCollection 2022.
3
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.与溃疡性结肠炎患者对粪便微生物群移植的反应相关的特定细菌和代谢物。
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.
4
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.粪便微生物移植对溃疡性结肠炎患者 8 周缓解的影响:一项随机临床试验。
JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046.
5
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.粪便移植治疗溃疡性结肠炎的随机对照试验结果。
Gastroenterology. 2015 Jul;149(1):110-118.e4. doi: 10.1053/j.gastro.2015.03.045. Epub 2015 Mar 30.
6
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.粪便微生物群移植在随机对照试验中诱导活动期溃疡性结肠炎患者缓解。
Gastroenterology. 2015 Jul;149(1):102-109.e6. doi: 10.1053/j.gastro.2015.04.001. Epub 2015 Apr 7.
7
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.真菌跨界动态与溃疡性结肠炎对粪便微生物群移植 (FMT) 治疗的反应性相关。
Cell Host Microbe. 2020 May 13;27(5):823-829.e3. doi: 10.1016/j.chom.2020.03.006. Epub 2020 Apr 15.
8
Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis.在接受捐赠者排便后,早期粪便微生物组转移决定了中重度溃疡性结肠炎患者的反应。
Indian J Gastroenterol. 2022 Aug;41(4):389-396. doi: 10.1007/s12664-022-01257-0. Epub 2022 Sep 19.
9
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
10
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility.活动性溃疡性结肠炎粪便微生物群移植的严格供体选择:一项因无效而提前终止的随机对照试验的关键经验教训
Clin Gastroenterol Hepatol. 2025 Mar;23(4):621-631.e7. doi: 10.1016/j.cgh.2024.05.017. Epub 2024 May 23.

引用本文的文献

1
The Role of Intestinal Fungi in the Pathogenesis and Treatment of Ulcerative Colitis.肠道真菌在溃疡性结肠炎发病机制及治疗中的作用
Microorganisms. 2025 Mar 31;13(4):794. doi: 10.3390/microorganisms13040794.
2
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.炎症性肠病中的微生物群移植疗法:进展与机制洞察
Gut Microbes. 2025 Dec;17(1):2477255. doi: 10.1080/19490976.2025.2477255. Epub 2025 Mar 10.
3
Comparative analysis of the gut bacteria and fungi in migratory demoiselle cranes () and common cranes () in the Yellow River Wetland, China.

本文引用的文献

1
Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome.肠易激综合征患者粪便白色假丝酵母菌的遗传和表型多样性。
Sci Rep. 2022 Mar 30;12(1):5391. doi: 10.1038/s41598-022-09436-x.
2
The Gut Microbiota in Inflammatory Bowel Disease.肠道微生物群与炎症性肠病。
Front Cell Infect Microbiol. 2022 Feb 22;12:733992. doi: 10.3389/fcimb.2022.733992. eCollection 2022.
3
Fungal microbiome in inflammatory bowel disease: a critical assessment.炎症性肠病中的真菌微生物组:批判性评估。
中国黄河湿地迁徙的凤头麦鸡和普通鹤肠道细菌与真菌的比较分析。
Front Microbiol. 2024 Mar 20;15:1341512. doi: 10.3389/fmicb.2024.1341512. eCollection 2024.
4
overgrowth disrupts the gut microbiota in mice bearing oral cancer.过度生长会破坏患口腔癌小鼠的肠道微生物群。
Mycology. 2023 Oct 26;15(1):57-69. doi: 10.1080/21501203.2023.2256761. eCollection 2024.
5
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.炎症性肠病中粪便微生物群移植的当前观点
Indian J Gastroenterol. 2024 Feb;43(1):129-144. doi: 10.1007/s12664-023-01516-8. Epub 2024 Feb 9.
6
Effect of Different Feeds on the Fungi Microbiome of Suffolk Crossed with Tibetan Sheep.不同饲料对萨福克羊与藏羊杂交后代真菌微生物群的影响。
Life (Basel). 2023 Nov 14;13(11):2210. doi: 10.3390/life13112210.
7
Candida spp. in Human Intestinal Health and Disease: More than a Gut Feeling.肠道健康与疾病中的念珠菌属(Candida spp.):不只是一种直觉。
Mycopathologia. 2023 Dec;188(6):845-862. doi: 10.1007/s11046-023-00743-z. Epub 2023 Jun 9.
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI155786.
4
Thiopurines correct the effects of autophagy impairment on intestinal healing - a potential role for ARHGAP18/RhoA.硫嘌呤纠正自噬损伤对肠道愈合的影响 - ARHGAP18/RhoA 的潜在作用。
Dis Model Mech. 2021 Apr 1;14(4). doi: 10.1242/dmm.047233. Epub 2021 Apr 23.
5
Dietary Curdlan Enhances Bifidobacteria and Reduces Intestinal Inflammation in Mice.饮食性凝结多糖可增强双歧杆菌并减轻小鼠肠道炎症。
Nutrients. 2021 Apr 15;13(4):1305. doi: 10.3390/nu13041305.
6
is enriched in Crohn's disease intestinal tissue and impairs healing in mice.在克罗恩病肠道组织中丰富,并损害小鼠的愈合。
Science. 2021 Mar 12;371(6534):1154-1159. doi: 10.1126/science.abd0919.
7
Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption.巨噬细胞通过限制真菌产物吸收来维持上皮组织完整性。
Cell. 2020 Oct 15;183(2):411-428.e16. doi: 10.1016/j.cell.2020.08.048. Epub 2020 Sep 23.
8
Fungal Dysbiosis Aggravates Pouchitis in a Rat Model of Ileal Pouch Anal Anastomosis.真菌失调加重回肠贮袋肛管吻合术大鼠模型中的 pouchitis。
Inflamm Bowel Dis. 2020 Nov 19;26(12):1831-1842. doi: 10.1093/ibd/izaa111.
9
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis.真菌跨界动态与溃疡性结肠炎对粪便微生物群移植 (FMT) 治疗的反应性相关。
Cell Host Microbe. 2020 May 13;27(5):823-829.e3. doi: 10.1016/j.chom.2020.03.006. Epub 2020 Apr 15.
10
Host-microbiota interactions in inflammatory bowel disease.炎症性肠病中的宿主-微生物群相互作用。
Nat Rev Immunol. 2020 Jul;20(7):411-426. doi: 10.1038/s41577-019-0268-7. Epub 2020 Jan 31.